What is the maximum allowed dose of nebulized Albuterol for suspected hyperkalemia?

In cases of suspected hyperkalemia, nebulized albuterol is utilized as a bronchodilator that can also help drive potassium back into the cells, thereby reducing serum potassium levels. According to protocols, the maximum dose of nebulized albuterol that is typically recommended is 15 mg. This dose can effectively achieve the desired therapeutic outcome without exceeding safety margins for dosing, allowing for both effective management of respiratory issues and the additional benefit of potassium reduction.

The use of albuterol in hyperkalemia is based on its mechanism of action, which stimulates beta-2 adrenergic receptors, promoting the movement of potassium from the extracellular space into the cells. By keeping the dosage within the recommended limits, practitioners ensure that they are maximizing the therapeutic benefits while minimizing potential side effects associated with higher doses.